期刊
BLOOD
卷 112, 期 9, 页码 3704-3712出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-06-160945
关键词
-
类别
资金
- National Institutes of Health [RO1AI67545]
- Cancer Research Institute
- V Foundation for Cancer Research
- California Breast Cancer Research Program
- Pew Scholars Program
- Prevent Cancer Foundation
- NIH National Research Service Award [T32AI060536-02]
- Australian National Health and Medical Research Council
Although it is known that interleukin-7 (IL-7) and IL-15 influence the survival and turnover of CD8(+) T cells, less is known about how these cytokines affect different subsets during the course of the immune response. We find that IL-7 and IL-15 differentially regulate CD8(+) T-cell subsets defined by KLRG1 and CD127 expression during the contraction phase of the immune response. The provision of IL-15, or the related cytokine IL-2, during contraction led to the preferential accumulation of KLRG1(hi)CD127(lo) CD8(+) T cells, whereas provision of IL-7 instead favored the accumulation of KLRG1(lo)CD127(hi) cells. While IL-7 and IL-15 both induced proliferation of KLRG1(lo) cells, KLRG1(hi) cells exhibited an extraordinarily high level of resistance to cytokine-driven proliferation in vivo despite their dramatic accumulation upon IL-15 administration. These results suggest that IL-15 and IL-2 greatly improve the survival of KLRG1hi CD8(+) T cells, which are usually destined to perish during contraction, without inducing proliferation. As the availability of IL-15 and IL-2 is enhanced during periods of extended inflammation, our results suggest a mechanism in which a population of cytokine-dependent KLRG1(hi) CD8(+) T cells is temporarily retained for improved immunity. Consideration of these findings may aid in the development of immunotherapeutic strategies against infectious disease and cancer. (Blood. 2008; 112:3704-3712)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据